Research & Development News Channel

European Commission Launches Consultation on Pharmaceuticals

The European Commission has launched a consultation on the future of pharmaceuticals for human use in Europe, as a part of its programme to improve the regulatory, non-regulatory and research, technology and development framework for pharmaceuticals. In an explanatory note, the Commission highlights three major challenges impacting the pharmaceutical sector in Europe: the globalisation of the sector; the smooth functioning of the internal market; and advances in science and technology.

EU committee recommends omega-3 supplements during pregnancy

Pregnant women should take a daily supplement of omega-3 acids, an EU supported consensus committee has recommended. The supplement would increase the likelihood of a healthy birth and boost child development. The committee, composed of more than 50 nutritional experts from the EU-funded projects Perinatal Lipid Nutrition Group (PeriLip) and Early Nutrition Programming (EARNEST), said it had found that women who included DHA in their diet had healthier pregnancies, that their children had healthier birth weights and that they were less likely to give birth prematurely.

International Study Finds New Drugs Combination to Cut Deaths from Diabetes

The largest-ever study of treatments for diabetes has shown that a combination of two blood pressure-lowering drugs reduces the risk of death, heart attack and kidney disease in diabetes sufferers. The "Action in diabetes and vascular disease" (ADVANCE) project involves 20 countries from around the world, 12 of them from the EU. The results were presented at the European Society of Cardiology Congress in Vienna, Austria, on 3 September.

The Future of Pharmaceuticals for Human Use in Europe

The European pharmaceutical industry makes an irreplaceable contribution to Europe's wellbeing through the availability of medicines, economic growth and employment. The pharmaceutical sector has been and remains a key strategic sector for Europe.

Study Trends Online Professional Activities and Reveals Specialty-specific Marketing Opportunities

Manhattan Research, a healthcare market research services firm, announced the leading pharmaceutical product website destinations for physicians from its new physician research study, "ePharma Physician® v7.0: The Future of Professional eMarketing.". Manhattan Research recently hosted a webcast discussing highlights of the ePharma Physician® v7.0 research.

Putnam Associates Study Finds Insurers Want More Prescription Drug Use

Putnam Associates released today the results of an intensive study of U.S. health insurance plans' perceptions of branded prescription drug use in the U.S. The study revealed that plans believe greater pharmacoeconomic value can be unlocked by increasing patient use within certain drug categories.

Patients and Healthcare Providers to Experience Significant Benefits from the Use of the Internet

The growth of Internet applications in healthcare has been rapid. A growing number of patients are becoming increasingly involved in the healthcare service they receive. These 'power patients' possess characteristics that distinguish them from traditional patients and are an important factor in driving the use of the Internet in healthcare.

More Pharma News ...

Merck's Investigational Integrase Inhibitor for HIV

Research & Development News

European Commission Launches Consultation on Pharmaceuticals

EU committee recommends omega-3 supplements during pregnancy

International Study Finds New Drugs Combination to Cut Deaths from Diabetes

The Future of Pharmaceuticals for Human Use in Europe

Study Trends Online Professional Activities and Reveals Specialty-specific Marketing Opportunities

Putnam Associates Study Finds Insurers Want More Prescription Drug Use

Patients and Healthcare Providers to Experience Significant Benefits from the Use of the Internet

More Pharma News ...

Business & Industry

Research & Development

Conferences & Events

Regulatory Affairs